Joshua Brody – Press/Media — Icahn School of Medicine at Mount Sinai

View Scopus Profile

Emailjoshua.brodymssmedu

h-index

Research activity per year

If you made any changes in Pure these will be visible here soon.

1 - 25 out of 202 results
- Title
- Date(ascending)

Lymphoma Research Foundation Awards More Than $5.4 Million in Lymphoma Research Grants
Joshua Brody
2/05/23
77 items of Media coverage
Press/Media
Lymphoma Research Foundation Awards More Than $5.4 Million in Lymphoma Research Grants.
Joshua Brody
2/05/23
1 item of Media coverage
Press/Media
Experts Contextualize ASH Findings for Clinical Practice
Joshua Brody
23/01/23
1 item of Media coverage
Press/Media
Cancer vaccines being developed at the Tisch Cancer Institute at Mount Sinai
Thomas Marron & Joshua Brody
5/01/23
1 item of Media coverage
Press/Media
Studies from Icahn School of Medicine at Mount Sinai Reveal New Findings on Oncolytic Virotherapy (Expanding Cross-presenting Dendritic Cells Enhances Oncolytic Virotherapy and Is Critical for Long-term Anti-tumor Immunity)
Ranjan Upadhyay, Brian Brown, Joshua Brody, Miriam Merad & Adolfo Garcia-Sastre
30/12/22
1 item of Media coverage
Press/Media
New funding of $2 million for research bringing us one step closer to a cure for Follicular Lymphoma
Joshua Brody
28/11/22 → 29/11/22
14 items of Media coverage
Press/Media
Mount Sinai Health System: Potentially Serious Side Effect Seen in Patient after Immunotherapy
Samir Parekh, Miriam Merad, Seunghee Kim-Schulze, Joshua Brody, Adeeb Rahman, Sundar Jagannath, Alessandro Laganà, Charles Stacy, Julie Teruya-Feldstein & Deepu Madduri
10/12/21 → 11/12/21
8 items of Media coverage
Press/Media
CAR-T for advanced lymphoma: Options do not equal choice
Joshua Brody
29/07/21
1 item of Media coverage
Press/Media
SITC CPG Webinar - Case Studies in Immunotherapy for the Treatment of Lymphoma
Joshua Brody
17/06/21
1 item of Media coverage
Press/Media
Cancer vaccine helped keep melanoma under control for years in small study
Joshua Brody
21/01/21
2 items of Media coverage
Press/Media
Classical Hodgkin Lymphoma Updates from ASH 2020
Joshua Brody
28/12/20
2 items of Media coverage
Press/Media
Immunotherapy Continues on Positive Trajectory in Lymphoid Malignancies
Joshua Brody
28/12/20
1 item of Media coverage
Press/Media
Scientists Unlock Promising Key to Preventing Cancer Relapse After Immunotherapy.
Joshua Brody
17/12/20 → 18/12/20
2 items of Media coverage
Press/Media
Scientists Unlock Promising Key to Preventing Cancer Relapse...
Joshua Brody
18/12/20
1 item of Media coverage
Press/Media
Mount Sinai: Scientists Unlock Promising Key to Preventing Cancer Relapse After Immunotherapy
Joshua Brody
17/12/20
1 item of Media coverage
Press/Media
Scientists Unlock Promising Key to Preventing Cancer Relapse After...
Joshua Brody
17/12/20
11 items of Media coverage
Press/Media
Dr. Brody on the Role of Immunotherapy in Hodgkin Lymphoma
Joshua Brody
15/12/20
1 item of Media coverage
Press/Media
Dr. Brody on the Expanding Role of Venetoclax in MCL
Joshua Brody
5/12/20
1 item of Media coverage
Press/Media
Dr. Brody on Managing CAR T-Cell Therapy Toxicities in MCL
Joshua Brody
1/12/20
1 item of Media coverage
Press/Media
Dr. Brody on the Potential Role for Bispecific Antibodies in MCL
Joshua Brody
19/11/20
1 item of Media coverage
Press/Media
CAR T-Cell Combinations May Offer a Way to Overcome Antigen Escape in MCL
Joshua Brody
19/11/20
1 item of Media coverage
Press/Media
Dr. Brody on the Challenges of Antigen Escape in MCL
Joshua Brody
17/11/20
1 item of Media coverage
Press/Media
Nivolumab/Ipilimumab-Primed Immunotransplant for DLBCL
Joshua Brody
5/11/20
1 item of Media coverage
Press/Media
Study to Evaluate the Safety and Preliminary Efficacy of Ibrutinib and Pembrolizumab in Patients With Chronic Lymphocytic Leukemia (CLL) or Mantle Cell Lymphoma (MCL)
Joshua Brody
2/11/20
1 item of Media coverage
Press/Media
Style icon: Alexa Chung
Joshua Brody
15/10/20
1 item of Media coverage
Press/Media